Managing Director, Renascor Resources
| Role | Organisation | Sources |
|---|---|---|
| CEO | Otago Innovation Ltd | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
| Managing Director | Renascor Resources | @AuManufacturing |
Stories naming David Christensen. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Renascor's graphite purification trials reached battery-grade purity, supporting its Adelaide demonstration plant, which carries a $5 million Australian government critical minerals grant; plant commissioning is set for early next year.
Brandon Capital led a NZ$14 million investment in Amaroq Therapeutics, a University of Otago spinout developing RNA cancer therapies, with three co-investors and a Callaghan Innovation repayable grant supporting the deal.
University of Otago cancer RNA spinout Amaroq Therapeutics has raised NZ$14 million led by Brandon Capital with Otago Innovation, NZ Innovation Booster and Cure Kids Ventures to advance its lncRNA-targeting cancer therapies.
Also Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio